Skeletal muscle volume loss among liver cirrhosis patients receiving levocarnitine predicts poor prognosis

Sarcopenia has a negative impact on the prognosis of patients with liver cirrhosis (LC). We investigated the significance of skeletal muscle volume and its changes in LC patients taking levocarnitine (L-carnitine). We retrospectively analyzed 51 LC patients taking L-carnitine from December 2012 to M...

Descripción completa

Detalles Bibliográficos
Autores principales: Fujita, Masashi, Abe, Kazumichi, Hayashi, Manabu, Takahashi, Atsushi, Ohira, Hiromasa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360248/
https://www.ncbi.nlm.nih.gov/pubmed/32664122
http://dx.doi.org/10.1097/MD.0000000000021061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7360248/
https://www.ncbi.nlm.nih.gov/pubmed/32664122
http://dx.doi.org/10.1097/MD.0000000000021061

Ejemplares similares